TLIS

Talis Biomedical Corporation Common Stock
TLIS

Overview Fund Activity
Delisted

TLIS was delisted on the 30th of August, 2024.

Back to rankings

29 hedge funds and large institutions have $8.59M invested in Talis Biomedical Corporation Common Stock in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 9 reducing their positions, and 12 closing their positions.

Holders
29
Holders Change
-6
Holders Change %
-17.14%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
9
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Jane Street
1
Jane Street
New York
$20K
2
Man Group
2
Man Group
United Kingdom
$9K
3
TRCT
3
Tower Research Capital (TRC)
New York
$3K
4
BNP Paribas Financial Markets
4
BNP Paribas Financial Markets
France
$382

Top Sellers

1
ACH
1
ArrowMark Colorado Holdings
Colorado
$816K
2
NM
2
Newtyn Management
New York
$0
3
Morgan Stanley
3
Morgan Stanley
New York
$54K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$22K
5
Millennium Management
5
Millennium Management
New York
$88K
Name Holding Trade Value Shares
Change 		Shares
Change %
VF
26
Virtu Financial
New York
– -$16K -1,337 Closed
Two Sigma Investments
27
Two Sigma Investments
New York
– -$14K -1,187 Closed
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
– -$10K -834 Closed
M&T Bank
29
M&T Bank
New York
– -$10K -784 Closed
Fidelity Investments
30
Fidelity Investments
Massachusetts
– -$1K -92 Closed
1
2